|
1) 篠原幸夫, 小川 彰, 鈴木則宏, 他. 脳卒中ガイドライン2009. 1版. 東京: 協和企画; 2009. p.123-4
|
|
|
|
|
2) Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004; 351: 1493-501
|
|
|
|
|
3) Mantese VA, Timaran CH, Chiu D, et al. The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): stenting versus carotid endarterectomy for carotid disease. Stroke. 2010; 41 Suppl 1: S31-4
|
|
|
|
|
|
4) Brott TG, Halperin JL, Abbara S, et al. SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease. Stroke. 2011. in press (online Jan)
|
|
|
|
|
|
5) North American Symptomatic Carotid Endarterectomy Trial (NASCET) investigators. Clinical alert: benefit of carotid endarterectomy for patients with high-grade stenosis of the internal carotid artery. Stroke. 1991; 22: 816-7
|
|
|
|
|
|
6) Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for sympto-matic carotid stenosis. Lancet. 2003; 361: 107-16
|
|
|
|
|
|
7) Executive Committee for the Asymptomatic Carotid Atherosclerosis (ACAS) Study. Endarte-rectomy for asymptomatic carotid artery stenosis. JAMA. 1995; 273: 1421-8
|
|
|
|
|
|
8) Halliday A, Mansfield A, Marro J, et al. Pre-vention of disabling and fatal strokes by suc-cessful carotid endarterectomy in patients with-out recent neurological symptoms: randomised controlled trial. Lancet. 2004; 363: 1491-502
|
|
|
|
|
|
9) SPACE Collaborative Group. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet. 2006; 368: 1239-47
|
|
|
|
|
|
10) Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006; 355: 1660-71
|
|
|
|
|
|
11) International Carotid Stenting Study investigators. Carotid artery stenting compared with endarte-rectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet. 2010; 20: 985-97
|
|
|
|
|
|
12) The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008; 25: 457-507
|
|
|
|
|
|
13) Naggara O, Touzé E, Beyssen B, et al. Anatomical and technical factors associated with stroke or death during carotid angioplasty and stenting: results from the endarterectomy versus angio-plasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial and systematic review. Stroke. 2011; 42: 380-8
|
|
|
|
|
|
14) Bonati LH, Jongen LM, Haller S, et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol. 2010; 9: 353-62
|
|
|
|
|
|
15) Carotid Stenting Trialistsʼ Collaboration, Short-term outcome after stenting versus endarterec-tomy for symptomatic carotid stenosis: a preplan-ned meta-analysis of individual patient data. Lancet. 2010; 25: 1062-73
|
|
|
|
|
|
16) Howard VJ, Lutsep HL, Mackey A, et al. Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Lancet Neurol. 2011; 10: 530-7
|
|
|
|
|
|
17) 桑山直也, 遠藤俊郎, JCASグループ. 本邦における頸動脈治療の前向き登録(JCAS研究). 脈管学. 2010; 50: 723-7
|
|
|
|